Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 3
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Ponatinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021 3 0
Rapamycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 6 0
Amphotericin B Potential treatment - theoretical effect Used to treat other disease Antiviral Nov/10/2020 2 0
Raloxifene Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/04/2020 2 0
Digitoxin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/01/2020 5 0
Diammonium glycyrrhizinate Potential treatment - theoretical effect Experimental Antiviral Sep/24/2020 1 0
Rifaximin Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/24/2020 1 0
Excel (.xslx) CSV (.csv)